White Prilocaine powder cas 721-50-6 is an amide-type LA of fast onset and intermediate duration of action. White Prilocaine powder cas 721-50-6 is similar to that of lidocaine, being rapidly metabolized by the liver and excreted in the urine as o-toluidine.
Product introduction:
CAS: 721-50-6
MF: C13H20N2O
MW: 220.31
Appearance: White or light yellow, waxy solid
Solubility: Very soluble in alcohol and in acetone;slightly soluble in water.
Description: White Prilocaine powder cas 721-50-6 is an amide-type LA of fast onset and intermediate duration of action. White Prilocaine powder cas 721-50-6 is similar to that of lidocaine, being rapidly metabolized by the liver and excreted in the urine as o-toluidine. The main adverse effect of prilocaine is a dose-dependent production of methaemoglobinaemia resulting in impaired oxygen-carrying capacity. Cyanosis may occur 2–3 hours following administration. The local and systemic adverse effects of prilocaine on the CNS and heart are similar to those of lidocaine.
Application: White Prilocaine powder cas 721-50-6 is a topical anesthetic that causes loss of feeling in the skin and surrounding tissues. It is used to numb the skin before procedures or injections. It has similar function with lidocaine.
Other chemical names: N-(2-methylphenyl)-2-(propylamino)propionamide, Prilocaine N-(2-Methylphenyl)-2-propylamino-propanamide, Astra 1512
Certificate of analysis
|
Item of Analysis |
Standard |
Result of Analysis |
|
Description |
White or almost white powder |
Complies |
|
Complies Very soluble in alcohol and in acetone;slightly soluble in water. |
Complies |
|
|
Melting Point |
36℃~39℃ |
37.9℃~38.5℃ |
|
Identification |
By IR, to match with the working standard |
Conforms |
|
O-Toluidine |
≤0.01% |
Conforms |
|
Impurity A |
≤0.2% |
0.17% |
|
Moisture |
≤0.5% |
0.45% |
|
Residue on ignition |
≤0.1% |
0.05% |
|
Residual solvents |
Should be to match with the standard |
Conforms |
|
Assay |
99.0%-101% |
99.50% |